Fasted Bioavailability Study of Cilostazol Tablets, 50mg

Clinical trial NCT00685802 · COMPLETED

Trial details

NCT number: NCT00685802
Sponsor: Mutual Pharmaceutical Company, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Therapeutic Equivalency, Healthy

Start date: 2004-06-01
Primary completion: 2004-07-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.